The American Society of Cataract and Refractive Surgery 2023 annual meeting in San Diego will showcase the latest clinical data and technology advancements in the field of ophthalmology. The four-day conference will offer lectures, symposia, workshops, sessions, courses, and skills transfer labs to help ophthalmic professionals improve their clinical and administrative skills. Companies such as ViaLase Inc. and Aurion Biotech will present their clinical data and technology innovations to the ophthalmic community, highlighting their potential impact to practices and patients alike. ViaLase will present its first-in-human clinical data on femtosecond laser image-guided high-precision trabeculotomy (FLigHT) treatment for glaucoma, while Aurion Biotech will present its clinical trial results from its Escalón study, using its novel cell therapy to treat corneal endothelial disease. This year’s annual meeting offers an exciting opportunity for ophthalmic professionals to learn about the newest industry trends and innovations, network with their peers, and improve their skills for the benefit of their patients.
**Related Facts:**
– The American Society of Cataract and Refractive Surgery is a professional organisation dedicated to advancing the field of ophthalmology worldwide.
– The society has over 9,000 members in more than 100 countries.
– Ophthalmology is the branch of medicine that deals with the anatomy, physiology, and diseases of the eye.
**Key Takeaway:**
The American Society of Cataract and Refractive Surgery 2023 annual meeting is a must-attend event for ophthalmic professionals looking to stay up-to-date on the latest clinical techniques, industry trends, and technology advancements. The meeting offers a unique opportunity for networking and knowledge sharing, and companies such as ViaLase Inc. and Aurion Biotech will present their clinical data and technology innovations to the ophthalmic community, highlighting their potential impact on glaucoma and corneal endothelial disease treatment.
**Conclusion:**
The American Society of Cataract and Refractive Surgery 2023 annual meeting is an exciting event for ophthalmic professionals, offering the latest clinical data and technology advancements in the field. Companies such as ViaLase Inc. and Aurion Biotech will showcase their innovative treatments for glaucoma and corneal endothelial disease, highlighting the potential benefits to practices and patients alike. The educational opportunities and networking events offered at the annual meeting make it a must-attend for professionals looking to stay ahead of the curve in the field of ophthalmology.
